Novoseven Kit
Product Images NDC 0169-7201

Product Visual Gallery

This gallery contains 43 technical images submitted to the FDA as part of the official labeling for Novoseven (NDC 0169-7201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph: Pt Versus Fvii:c (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 03)

A scatter plot titled 'PT versus FVII:C' showing the relationship between PT (sec) on the vertical axis and FVII:C (unit per mL) on the horizontal axis. Data points illustrate a general trend where PT decreases as FVII:C levels increase, with values ranging from 0 to approximately 14 seconds for PT and 0 to 40 units per mL for FVII:C.*

FDA Label Image

Figure A (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 04)

A line graph showing TF-initiated clotting over time in minutes, with Thrombin Antithrombin (TAT) levels in nM on the vertical axis. The graph compares clotting in normal blood and congenital hemophilia A blood with or without addition of 10 nM factor VIIa and TF initiation, illustrating thrombin generation over 20 minutes.*

FDA Label Image

Figure B (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 05)

A line graph depicting TF-initiated clotting of normal and hemophilia A platelet-rich plasma over time, showing fluorescence units versus time in minutes. Multiple lines compare normal plasma and hemophilia plasma with increasing concentrations of recombinant Factor VIIa (rFVIIa), illustrating clotting activity across different conditions.*

FDA Label Image

1 mg. Carton (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 22)

NovoSeven RT Coagulation Factor VIIa (Recombinant) 1 mg kit packaging label. The label shows the proprietary and generic names, dosage strength of 1 mg, and kit dosage form. It is labeled as a plasma derivative by Novo Nordisk. The carton includes storage instructions, active ingredient details, barcodes, and manufacturer information from Novo Nordisk, Bagsvaerd, Denmark.*

FDA Label Image

2 mg. Carton (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 23)

Packaging label for NovoSeven RT Coagulation Factor VIIa (Recombinant) kit. The label shows the 2 mg dosage strength with details on storage, contents, and usage as a plasma derivative product. Manufactured by Novo Nordisk, the label includes NDC barcode and lot information areas on a predominantly white and blue background.*

FDA Label Image

5 mg. Carton (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 24)

NovoSeven RT 5 mg kit packaging label for Coagulation Factor VIIa (Recombinant). The label shows storage instructions, active ingredient details, and the labeler Novo Nordisk, including their address in Denmark and the U.S. The package advises room temperature storage and includes a barcode and lot information space.*

FDA Label Image

8 mg. Carton (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 25)

Packaging label for NovoSeven RT kit containing Coagulation Factor VIIa (Recombinant) at 8 mg strength. The label displays dosing and ingredient details, storage as room temperature stable, and manufacturer information for Novo Nordisk.*

FDA Label Image

2 mL Histidine Syringe.jpg (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 31)

Label for Histidine 10 mmol solution, 2 mL for reconstitution of NovoSeven RT 2 mg. The label includes storage instructions (2-25°C/36-77°F), a barcode, product NDC 0169-7012-98, and states it is Rx only. Manufactured by Novo Nordisk Inc., with their contact number 1-877-NOVO-777. The label also has space for Expiration Date and Lot Number.*

FDA Label Image

5 mL Histidine Syringe.jpg (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 32)

Label for NovoSeven RT Histidine (10 mmol solution) 5 mL vial used for reconstitution of NovoSeven RT 5 mg. The label includes a volume scale up to 10 mL, storage instruction between 2-25°C (36-77°F), and contact information for Novo Nordisk Inc. It also shows a barcode and space for expiration date and lot number.*

FDA Label Image

1 mg. Peel-off Vial Label (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 34)

NovoSeven RT 1 mg kit label showing Coagulation Factor VIIa (Recombinant) as the active ingredient. The label indicates room temperature storage between 2-25°C and specifies reconstitution with 1 mL histidine diluent only. The label includes the brand and generic names, strength, dosage form as kit, and the labeler Novo Nordisk Inc. Contact number and barcode are also visible.*

FDA Label Image

2 mg. Peel-off Vial Label (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 35)

Label for NovoSeven RT 2 mg kit, containing Coagulation Factor VIIa (Recombinant) for intravenous administration. The label includes storage instructions to keep the product between 2-25°C (36-77°F) and directions for reconstitution with 2 ml histidine diluent only. It also displays the Novo Nordisk labeler information and a barcode.*

FDA Label Image

5 mg. Peel-off Vial Label (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 36)

NovoSeven RT 5 mg kit packaging label showing product name and strength as Coagulation Factor VIIa (Recombinant). The label includes storage instructions between 2-25°C, indicates room temperature stability, and mentions reconstitution with 5 mL histidine diluent only. It is labeled as Rx only and manufactured by Novo Nordisk Inc.*

FDA Label Image

8 mg. Peel-off Vial Label (9f903efb 9166 47f1 Abf4 B2180cd5f9f8 37)

Label for NovoSeven RT 8 mg kit containing Coagulation Factor VIIa (Recombinant). The label indicates it is a room temperature stable plasma derivative for bolus intravenous administration, with storage between 2-25°C (36-77°F). It includes reconstitution instructions with 8 mL histidine diluent and contact information for Novo Nordisk Inc.*

FDA Label Image

1 Vial Of Novoseven Rt Powder And 1 Vial Of Histidine Diluent (Image 01)

An instructional illustration showing two vials labeled 'Diluent vial' and 'Powder vial,' each with a plastic cap and a rubber stopper. The diagram highlights the vial components for the NovoSeven RT coagulation factor VIIa (recombinant) kit by Novo Nordisk.*

FDA Label Image

Novoseven Rt Package Containing 1 Vial Of Powder And 1 Pre-filled Histidine Diluent Syringe With Vial Adapter (Image 02)

An instructional diagram showing components of the NovoSeven RT kit by Novo Nordisk. It includes a vial with NovoSeven RT powder sealed by a rubber stopper under a plastic cap, a vial adapter with a spike under a protective cap covered by protective paper, a pre-filled syringe with diluent featuring a syringe tip under a syringe cap and scale markings, and a plunger rod separate from the syringe.*

FDA Label Image

2.1 mL Histidine (Image 03)

Label for NovoSeven RT Histidine (10 mmol solution) 2.1 mL vial for reconstitution of NovoSeven RT 2 mg. The label includes storage instructions to keep between 2-25°C and provides a barcode and lot number area. The labeler is Novo Nordisk Inc.*

FDA Label Image

5.2 mL Histidine (Image 04)

Label for NovoSeven RT 5 mg reconstitution kit containing 5.2 mL of Histidine (10 mmol solution) as diluent. The label includes storage instructions between 2-25°C (36-77°F), prescription-only designation, labeler information Novo Nordisk Inc., and contact number 1-877-NOVO-777. Also shown are the NDC 0169-7005-98 and spaces for expiration date/lot number.*

FDA Label Image

1 mL Histidine Syringe (Image 05)

Label for Histidine 10 mmol solution 1 mL for reconstitution of NovoSeven RT 1 mg. The label includes a volume scale in mL, an expiration date and lot number area, a barcode, and Novo Nordisk contact information. Storage temperature instructions (2-25°C or 36-77°F) and Rx only indication are also present.*

FDA Label Image

1 mg. Vial (Image 06)

NovoSeven RT 1 mg kit label showing coagulation factor VIIa (recombinant) for intravenous use. The label indicates room temperature stability with storage between 2 to 25°C (36 to 77°F). It includes reconstitution instructions with 1.1 mL histidine diluent and displays the manufacturer Novo Nordisk along with their contact number.*

FDA Label Image

2 mg. Vial (Image 07)

NovoSeven RT 2 mg kit label displaying the product name with Coagulation Factor VIIa (Recombinant) as the active ingredient. The label states it is room temperature stable, for bolus intravenous administration, and should be stored between 2-25°C (36-77°F). It is labeled for Rx use only and includes the manufacturer Novo Nordisk with a contact number.*

FDA Label Image

5 mg. Vial (Image 08)

NovoSeven RT 5 mg kit containing Coagulation Factor VIIa (Recombinant) by Novo Nordisk. The label notes room temperature stability, instructions for bolus intravenous administration, reconstitution with 5.2 mL histidine diluent only, and storage between 2-25°C (36-77°F). Includes barcode and contact information for Novo Nordisk.*

FDA Label Image

1.1 mL Histidine (Image 09)

Label from NovoSeven RT kit showing Histidine 10 mmol solution in a 1.1 mL volume for reconstitution. Includes storage instructions (2-25°C), manufacturer info (Novo Nordisk Inc.), and the product's NDC barcode and number.*

FDA Label Image

8 mL Histidine Syringe (Image 10)

Label for Histidine (10 mmol solution) 8 mL for reconstitution of NovoSeven RT 8 mg. The label includes storage instructions between 2-25°C (36-77°F), Rx only designation, NDC 0169-7018-98, and labeler information Novo Nordisk Inc. Contact number 1-877-NOVO-777 is also shown.*

FDA Label Image

Image 11

Packaging label for NovoSeven RT 1 mg kit containing Coagulation Factor VIIa (Recombinant) by Novo Nordisk. The label includes dosage instructions, storage information, and an illustration of the vial with a red cap and pre-filled diluent syringe included in the kit.*

FDA Label Image

Image 12

Packaging label for NovoSeven RT 2 mg kit containing Coagulation Factor VIIa (Recombinant) by Novo Nordisk. The label shows product name, dosage strength, and details including NDC code 0169-7202-01, instructions for room temperature stability, single-dose vial, and components included such as MaxiPro vial, vial adapter, and pre-filled diluent syringe. The label features blue and red markings with an illustration of the vial and syringe.*

FDA Label Image

Image 13

Packaging label for NovoSeven RT 5 mg kit, containing Coagulation Factor VIIa (Recombinant). The label shows the product name, strength (5 mg), dosage form as a kit including a vial adapter and pre-filled diluent syringe. It is labeled for intravenous administration and produced by Novo Nordisk. The design includes a barcode and trademark symbols, with text specifying room temperature storage and usage instructions.*

FDA Label Image

Image 14

Packaging label for NovoSeven RT 8 mg kit, containing Coagulation Factor VIIa (Recombinant). The label shows kit contents including a vial adapter and pre-filled diluent syringe. It is labeled for intravenous use and manufactured by Novo Nordisk. The label includes NDC 0169-7208-01 and graphical images of the product components.*

FDA Label Image

Image 27

Illustration showing components of the NovoSeven RT kit for Coagulation Factor VIIa (Recombinant). It includes a vial with NovoSeven RT powder sealed with a plastic cap and rubber stopper, a vial adapter with protective cap and spike, a pre-filled syringe with diluent including a rubber plunger and syringe cap, and a plunger rod with a wide top end and threaded section.*

FDA Label Image

Image 28

Instructional illustration showing hands preparing a component, likely a vial or syringe, as part of the NovoSeven RT kit usage process for Coagulation Factor VIIa (Recombinant). The image highlights manual handling of the medication device components.*

FDA Label Image

Image 29

An instructional illustration showing a hand gripping a small vial or container, with an arrow indicating the action of twisting or removing the cap. This image likely demonstrates a step in the preparation or use of a NovoSeven RT coagulation factor VIIa recombinant kit.*

FDA Label Image

Image 30

An instructional illustration showing hands demonstrating how to peel or remove a seal, likely from a vial or container, as part of the preparation process for NovoSeven RT (Coagulation Factor VIIa, Recombinant) kit.*

FDA Label Image

Image 31

An instructional illustration showing a hand pressing down on a vial's stopper or cap, with a downward arrow indicating the direction of pressure to secure or open the vial. The background is light blue with a letter 'D' in the corner, suggesting a step in a multi-step process.*

FDA Label Image

Image 32

Instructional illustration showing a hand removing a cap from a vial or container, indicated by an upward arrow. The inset highlights a close-up of the cap removal step. The image is part of the usage instructions for NovoSeven RT coagulation factor VIIa recombinant kit.*

FDA Label Image

Image 33

An instructional illustration showing hands holding a medical device, indicating to rotate or turn a part of the device in the direction of the arrow. This image is likely part of a usage guide for the NovoSeven RT kit by Novo Nordisk.*

FDA Label Image

Image 34

An instructional illustration showing a person holding two medical components, with an arrow indicating the action of connecting or assembling the parts, likely as part of preparing a medication kit such as NovoSeven RT coagulation factor.*

FDA Label Image

Image 35

NovoSeven RT kit packaging label from Novo Nordisk. The box features the proprietary name NovoSeven RT and indicates it contains Coagulation Factor VIIa (Recombinant). The packaging design includes blue and white color blocks with Novo Nordisk logo and kit identification information.*

FDA Label Image

Image 36

An instructional illustration showing two hands separating the cap from a vial or syringe connector by pulling it apart, indicated by an upward arrow. The illustration includes a blue hospital 'H' symbol in the top left corner, suggesting a medical setting. No text other than the symbol is visible.*

FDA Label Image

Image 37

An instructional illustration showing the process of preparing a syringe by drawing liquid from a vial or similar container, indicated by a hand holding the syringe and an arrow pointing down to the plunger being pulled back.*

FDA Label Image

Image 38

An instructional illustration depicting a hand holding a syringe attached to a vial, with an arrow indicating a circular motion around the vial, likely demonstrating how to mix or prepare the contents before use. The image uses simple line art on a blue background.*

FDA Label Image

Image 39

NovoSeven RT kit packaging label displaying the proprietary name NovoSeven RT and its generic name Coagulation Factor VIIa (Recombinant). The label indicates it is a plasma derivative product in kit form, labeled by Novo Nordisk. The label includes product information, barcode, and regulatory text.*

FDA Label Image

Image 40

An instructional illustration showing a hand holding a syringe attached to a vial or cartridge. A downward arrow next to the syringe indicates the direction for pushing or drawing liquid. The background is light blue with a small blue square labeled 'K' in the top left corner. This image appears to be part of a medication preparation or administration guide.*

FDA Label Image

Image 41

An instructional illustration showing two hands assembling components of a medical kit, with an arrow indicating the direction to connect or twist parts together. The image is part of the assembly or preparation process for the NovoSeven RT Kit, a coagulation factor VIIa (recombinant) plasma derivative from Novo Nordisk.*

FDA Label Image

Image 42

An instructional illustration showing the process of attaching a syringe to a vial and preparing it over a circular container with segmented sections. The syringe is shown inserting or removing fluid from the vial, indicating a preparation step likely related to the NovoSeven RT kit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.